Next, we evaluated the response of patient‐derived uLMS cells to MMP14 inhibition and compared it with the response of less aggressive low‐grade endometrial stromal sarcoma (LG‐ESS) cells. Here, MMP14 is linked to endometrioid stromal sarcoma.